GW&K Investment Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
VCM
VPM
DAM
GW&K Investment Management's RMD Position: Q1 2026 in Review
GW&K Investment Management reduced its ResMed (RMD) stake by 5.5% in Q1 2026, selling an estimated $1.5K and leaving 104 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #734.
GW&K Investment Management first reported a position in RMD in Q2 2013 and has held it in 20 quarters since. The position peaked at $4.47M in Q2 2014. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- GW&K Investment Management held 104 shares of ResMed worth $23K as of Q1 2026.
- GW&K Investment Management sold 6 ResMed shares in Q1 2026, an estimated $1.5K.
- ResMed made up ﹤0.01% of GW&K Investment Management's portfolio in Q1 2026, its #734 holding.
- GW&K Investment Management first reported a position in ResMed in Q2 2013 and has held it in 20 quarters since.
- GW&K Investment Management's ResMed position peaked at $4.47M in Q2 2014.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on GW&K Investment Management's 13F filing for Q1 2026, filed 13 May 2026.